Sponsor Dossier
AstraZeneca
Sponsor Dossier for AstraZeneca. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANDEXXA
- Brand: ARIMIDEX
- Brand: ARX-Ticagrelor
- Brand: BETALOC
- Brand: BEVESPI
- Brand: BREZTRI AEROSPHERE
- Brand: BRICANYL
- Brand: BRILINTA
About
AstraZeneca is an Australian Private Company with ABN 54009682311, registered in NSW and currently active. The company operates under several trading names including FOCUS PHARMACEUTICALS and STUART PHARMACEUTICALS.
Portfolio
AstraZeneca maintains 45 brands on the ARTG, of which 41 are indexable. The portfolio includes 39 brands with Product Information on file, 24 brands with PBAC outcome(s) on record, and 13 brands with AusPAR(s) on record.
Therapeutic focus
— Oncology: 15 brands — Respiratory: 10 brands — Endocrinology: 6 brands — Immunology: 5 brands — Cardiology: 5 brands — Infectious Disease: 2 brands — Gastroenterology: 1 brand — Haematology: 1 brand
PBS footprint
AstraZeneca has 16 brands with at least one PBS-listed item. The portfolio most recently touched the PBS schedule on 2026-05-01.
Regulatory activity
The most recent PBAC outcome for AstraZeneca was recorded on 2025-11-01, with 24 brands holding PBAC outcomes on record. The latest AusPAR was issued on 2025-05-20, with 13 brands holding AusPAR(s) on record.